cilostazol and Kidney Failure, Chronic studies

cilostazol and Kidney Failure, Chronic

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research Excerpts

Excerpt	Relevance	Reference
"Effects of cilostazol on preventing restenosis after PTA in these patients were investigated."	1.35	Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease. ( Aoyama, T; Ishii, H; Kumada, Y; Maruyama, S; Matsubara, T; Matsuo, S; Murohara, T; Takahashi, H; Toriyama, T; Yamada, S; Yasuda, Y; Yuzawa, Y, 2008)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (33.33)

29.6817

2010's

2 (66.67)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Chancharoenthana, W	1
Leelahavanichkul, A	1
Taratummarat, S	1
Wongphom, J	1
Tiranathanagul, K	1
Eiam-Ong, S	1
Ishii, H	2
Kumada, Y	2
Toriyama, T	2
Aoyama, T	2
Takahashi, H	2
Tanaka, M	1
Kamoi, D	1
Kawamura, Y	1
Yamada, S	2
Hayashi, M	1
Yasuda, Y	2
Yuzawa, Y	2
Maruyama, S	2
Matsuo, S	2
Matsubara, T	2
Murohara, T	2

Studies

Chancharoenthana, W

Leelahavanichkul, A

Taratummarat, S

Wongphom, J

Tiranathanagul, K

Eiam-Ong, S

Ishii, H

Kumada, Y

Toriyama, T

Aoyama, T

Takahashi, H

Tanaka, M

Kamoi, D

Kawamura, Y

Yamada, S

Hayashi, M

Yasuda, Y

Yuzawa, Y

Maruyama, S

Matsuo, S

Matsubara, T

Murohara, T

Other Studies

3 other studies available for cilostazol and Kidney Failure, Chronic

Article	Year
Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease. PloS one, 2017, Volume: 12, Issue:12 Topics: Animals; Cilostazol; Disease Models, Animal; Hyperplasia; Kidney Failure, Chronic; Mice; Nephrectomy	2017
Effects of oral cilostazol 100 mg BID on long-term patency after percutaneous transluminal angioplasty in patients with femoropopliteal disease undergoing hemodialysis: a retrospective chart review in Japanese patients. Clinical therapeutics, 2010, Volume: 32, Issue:1 Topics: Aged; Angioplasty, Balloon; Asian People; Cilostazol; Female; Femoral Artery; Follow-Up Studies; Hum	2010
Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease. Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:4 Topics: Aged; Angioplasty, Balloon; Cilostazol; Constriction, Pathologic; Female; Humans; Kaplan-Meier Estim	2008

Article

Year

Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease.

PloS one, 2017, Volume: 12, Issue:12

Topics: Animals; Cilostazol; Disease Models, Animal; Hyperplasia; Kidney Failure, Chronic; Mice; Nephrectomy

2017

Effects of oral cilostazol 100 mg BID on long-term patency after percutaneous transluminal angioplasty in patients with femoropopliteal disease undergoing hemodialysis: a retrospective chart review in Japanese patients.

Clinical therapeutics, 2010, Volume: 32, Issue:1

Topics: Aged; Angioplasty, Balloon; Asian People; Cilostazol; Female; Femoral Artery; Follow-Up Studies; Hum

2010

Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease.

Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:4

Topics: Aged; Angioplasty, Balloon; Cilostazol; Constriction, Pathologic; Female; Humans; Kaplan-Meier Estim

2008